ENTO logo

Entero Therapeutics (ENTO) Return On Assets

Annual ROA

-229.47%
+39.47%+14.68%

December 31, 2023


Summary


Performance

ENTO ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENTOprofitabilitymetrics:

Quarterly ROA

-14.69%
+7.97%+35.17%

September 1, 2024


Summary


Performance

ENTO Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENTOprofitabilitymetrics:

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

ENTO ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.7%+94.7%
3 y3 years+9.2%+92.1%
5 y5 years-26.6%+92.7%

ENTO ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+53.8%at high+97.6%
5 y5-year-34.6%+53.8%at high+97.6%
alltimeall time-158.7%+53.8%at high+97.6%

Entero Therapeutics ROA History

DateAnnualQuarterly
Sep 2024
-
-14.69%(-35.2%)
Jun 2024
-
-22.66%(-0.4%)
Mar 2024
-
-22.75%(-91.8%)
Dec 2023
-229.47%(-14.7%)
-278.66%(-5.7%)
Sep 2023
-
-295.45%(+87.6%)
Jun 2023
-
-157.51%(-15.2%)
Mar 2023
-
-185.68%(-27.5%)
Dec 2022
-268.94%(-45.8%)
-
Dec 2022
-
-256.23%(-14.3%)
Sep 2022
-
-298.97%(-51.2%)
Jun 2022
-
-612.53%(+18.5%)
Mar 2022
-
-516.74%(+23.5%)
Dec 2021
-496.50%(+96.4%)
-418.32%(-7.8%)
Sep 2021
-
-453.64%(+75.5%)
Jun 2021
-
-258.47%(+0.3%)
Mar 2021
-
-257.63%(-11.9%)
Dec 2020
-252.80%
-292.41%(+79.6%)
Sep 2020
-
-162.80%(-11.9%)
DateAnnualQuarterly
Jun 2020
-
-184.89%(+5.9%)
Mar 2020
-
-174.66%(+6.2%)
Dec 2019
-170.48%(-5.9%)
-164.49%(-18.6%)
Sep 2019
-
-202.02%(+7.3%)
Jun 2019
-
-188.29%(+18.8%)
Mar 2019
-
-158.52%(-3.3%)
Dec 2018
-181.19%(-10.5%)
-163.87%(+6.0%)
Sep 2018
-
-154.55%(-9.8%)
Jun 2018
-
-171.41%(-5.4%)
Mar 2018
-
-181.10%(+8.1%)
Dec 2017
-202.50%(-6.3%)
-167.47%(-18.4%)
Sep 2017
-
-205.15%(-4.9%)
Jun 2017
-
-215.79%(-14.8%)
Mar 2017
-
-253.24%(+9.4%)
Dec 2016
-216.05%(+143.6%)
-231.38%(+51.2%)
Sep 2016
-
-153.06%(+20.3%)
Jun 2016
-
-127.26%(+22.8%)
Mar 2016
-
-103.59%(+16.8%)
Dec 2015
-88.70%
-88.70%

FAQ

  • What is Entero Therapeutics annual return on assets?
  • What is the all time high annual ROA for Entero Therapeutics?
  • What is Entero Therapeutics annual ROA year-on-year change?
  • What is Entero Therapeutics quarterly return on assets?
  • What is the all time high quarterly ROA for Entero Therapeutics?
  • What is Entero Therapeutics quarterly ROA year-on-year change?

What is Entero Therapeutics annual return on assets?

The current annual ROA of ENTO is -229.47%

What is the all time high annual ROA for Entero Therapeutics?

Entero Therapeutics all-time high annual return on assets is -88.70%

What is Entero Therapeutics annual ROA year-on-year change?

Over the past year, ENTO annual return on assets has changed by +39.47% (+14.68%)

What is Entero Therapeutics quarterly return on assets?

The current quarterly ROA of ENTO is -14.69%

What is the all time high quarterly ROA for Entero Therapeutics?

Entero Therapeutics all-time high quarterly return on assets is -14.69%

What is Entero Therapeutics quarterly ROA year-on-year change?

Over the past year, ENTO quarterly return on assets has changed by +263.97% (+94.73%)